Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 117

1.

Passive Leg Raising After Left Ventricular Assist Device Implantation.

Ram E, Dourov D, Berkenstadt H, Lavee J, Kassif Y, Peled-Potashnik Y, Kogan D, Preisman S, Raanani E, Kogan A.

ASAIO J. 2018 Aug 14. doi: 10.1097/MAT.0000000000000870. [Epub ahead of print]

PMID:
30379654
2.

Post-Market Experience with HeartMate 3 Left Ventricular Assist Device: 30-Day Outcomes from ELEVATE.

Garbade J, Gustafsson F, Shaw S, Lavee J, Saeed D, Pya Y, Krabatsch T, Schmitto JD, Morshuis M, Chuang J, Zimpfer D.

Ann Thorac Surg. 2018 Oct 3. pii: S0003-4975(18)31349-3. doi: 10.1016/j.athoracsur.2018.07.092. [Epub ahead of print]

PMID:
30291831
3.

Intrapatient variability in tacrolimus trough levels after solid organ transplantation varies at different postoperative time periods.

Gueta I, Markovits N, Yarden-Bilavsky H, Raichlin E, Freimark D, Lavee J, Loebstein R, Peled Y.

Am J Transplant. 2018 Oct 3. doi: 10.1111/ajt.15134. [Epub ahead of print] No abstract available.

PMID:
30282112
4.

An international multicenter experience of biventricular support with HeartMate 3 ventricular assist systems.

Lavee J, Mulzer J, Krabatsch T, Marasco S, McGiffin D, Garbade J, Schmitto JD, Zimpfer D, Potapov EV.

J Heart Lung Transplant. 2018 Aug 17. pii: S1053-2498(18)31600-0. doi: 10.1016/j.healun.2018.08.008. [Epub ahead of print]

PMID:
30241889
5.

Trends and Outcomes in Heart Transplantation over the Past Three Decades: A Single Tertiary Center Experience in Israel.

Peled Y, Freimark D, Har-Zahav Y, Nachum E, Kogan A, Kassif Y, Lavee J.

Isr Med Assoc J. 2018 Sep;20(9):567-572.

6.

Six-month outcomes after treatment of advanced heart failure with a full magnetically levitated continuous flow left ventricular assist device: report from the ELEVATE registry.

Gustafsson F, Shaw S, Lavee J, Saeed D, Pya Y, Krabatsch T, Schmitto J, Morshuis M, Chuang J, Damme L, Zimpfer D, Garbade J.

Eur Heart J. 2018 Oct 1;39(37):3454-3460. doi: 10.1093/eurheartj/ehy513.

PMID:
30165521
7.

Donor-recipient ethnic mismatching impacts short- and long-term results of heart transplantation.

Peled Y, Loewenthal R, Kassif Y, Raichlin E, Younis A, Younis A, Nachum E, Freimark D, Goldenberg I, Lavee J.

Clin Transplant. 2018 Oct;32(10):e13389. doi: 10.1111/ctr.13389. Epub 2018 Sep 27.

PMID:
30144324
8.

High tacrolimus trough level variability is associated with rejections after heart transplant.

Gueta I, Markovits N, Yarden-Bilavsky H, Raichlin E, Freimark D, Lavee J, Loebstein R, Peled Y.

Am J Transplant. 2018 Oct;18(10):2571-2578. doi: 10.1111/ajt.15016. Epub 2018 Aug 13.

PMID:
29989311
9.
10.

Comparison of patients with multivessel disease treated at centers with and without on-site cardiac surgery.

Ram E, Goldenberg I, Kassif Y, Segev A, Lavee J, Shlomo N, Raanani E.

J Thorac Cardiovasc Surg. 2018 Mar;155(3):865-873.e3. doi: 10.1016/j.jtcvs.2017.09.144. Epub 2017 Nov 9.

PMID:
29452484
11.

Heart Transplantation in a Left Ventricular Assist Device Recipient After Donor's Extracorporeal Membrane Oxygenation Support: Is It Safe?

Peled Y, Kassif Y, Kogan A, Freimark D, Lavee J.

Transplantation. 2018 Apr;102(4):e185-e186. doi: 10.1097/TP.0000000000002059. No abstract available.

PMID:
29319628
12.

Management of Patients Who Receive an Organ Transplant Abroad and Return Home for Follow-up Care: Recommendations From the Declaration of Istanbul Custodian Group.

Domínguez-Gil B, Danovitch G, Martin DE, López-Fraga M, Van Assche K, Morris ML, Lavee J, Erlich G, Fadhil R, Busic M, Rankin G, Al-Rukhaimi M, OʼConnell P, Chin J, Norman T, Massari P, Kamel R, Delmonico FL; Declaration of Istanbul Custodian Group working group on ethical travel for transplantation.

Transplantation. 2018 Jan;102(1):e2-e9. doi: 10.1097/TP.0000000000001963.

PMID:
29019810
13.

Early aspirin initiation following heart transplantation is associated with reduced risk of allograft vasculopathy during long-term follow-up.

Peled Y, Lavee J, Raichlin E, Katz M, Arad M, Kassif Y, Peled A, Asher E, Elian D, Har-Zahav Y, Shlomo N, Freimark D, Goldenberg I, Klempfner R.

Clin Transplant. 2017 Dec;31(12). doi: 10.1111/ctr.13133.

PMID:
28990263
14.

Risk of early, intermediate, and late rejection following heart transplantation: Trends over the past 25 years and relation to changes in medical management. Tertiary center experience: The Sheba Heart Transplantation Registry.

Katz M, Freimark D, Raichlin E, Har-Zahav Y, Arad M, Kassif Y, Peled A, Asher E, Elian D, Kogan A, Shlomo N, Ofek E, Lavee J, Goldenberg I, Peled Y.

Clin Transplant. 2017 Oct;31(10). doi: 10.1111/ctr.13063. Epub 2017 Aug 21.

PMID:
28753240
15.

Metformin therapy reduces the risk of malignancy after heart transplantation.

Peled Y, Lavee J, Raichlin E, Katz M, Arad M, Kassif Y, Peled A, Asher E, Elian D, Har-Zahav Y, Shlomo N, Freimark D, Goldenberg I, Klempfner R.

J Heart Lung Transplant. 2017 Dec;36(12):1350-1357. doi: 10.1016/j.healun.2017.06.009. Epub 2017 Jun 23.

PMID:
28736111
16.
17.

Papers based on data concerning organs from executed prisoners should not be published: Response to Zheng and Yan.

Rogers WA, Fiatarone Singh MA, Lavee J.

Liver Int. 2017 May;37(5):771-772. doi: 10.1111/liv.13366. No abstract available.

PMID:
28453920
18.

The impact of gender mismatching on early and late outcomes following heart transplantation.

Peled Y, Lavee J, Arad M, Shemesh Y, Katz M, Kassif Y, Asher E, Elian D, Har-Zahav Y, Goldenberg I, Freimark D.

ESC Heart Fail. 2017 Feb;4(1):31-39. doi: 10.1002/ehf2.12107. Epub 2016 Aug 30.

19.

Age limitation for organ transplantation: the Israeli example.

Katvan E, Doron I, Ashkenazi T, Boas H, Carmiel-Haggai M, Elhalel MD, Shnoor B, Lavee J.

Age Ageing. 2017 Jan 8;46(1):8-10. doi: 10.1093/ageing/afw162.

PMID:
28181645
20.

Engaging with China on organ transplantation.

Rogers WA, Robertson MP, Lavee J.

BMJ. 2017 Feb 7;356:j665. doi: 10.1136/bmj.j665. No abstract available.

PMID:
28174156

Supplemental Content

Loading ...
Support Center